Money Follows the Person Rebalancing Grant Demonstration Program

by: Michael Saunders

The Centers for Medicare & Medicaid Services, more commonly referred to as CMS, is a federal agency operating within the United States Department of Health and Human Services that's primarily responsible for administering Medicare programs such as Medicaid, the State Children's Health Insurance Program (SCHIP), as well as health insurance portability standards.

The grants and programs of the CMS are all designed to contribute to the attainment of its general agency mission which is to ensure health care security for all its beneficiaries.

In keeping with this mission, the Centers for Medicare & Medicaid Services has recently established the Money Follows the Person Rebalancing Grant Demonstration Program wherein they aim to assist the states to balance their long-term care systems and help Medicaid enrollees transition from institutions to communities.

The Money Follows the Person (MFP) Rebalancing Demonstration Program possesses the ability to provide critical tools that can be utilized to address the gaps in the availability of community services for individuals with disabilities.

Furthermore, the programs gives the states the opportunity to serve more individuals in home and community-based settings and this can help them execute the integration mandate of the American Disability Act.

  (continued...)

Money Follows the Person Rebalancing Grant Demonstration Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Leadership Group for a Clinical Research Network on Antibacterial Resistance Program
In line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program.

---